NASDAQ:CTXR   Citius Pharmaceuticals, Inc.
PENNANT/ DESCENDING TRIANGLE ON CTXR. WITH CATALYST AHEAD OF PHASE 3 DATA FOR CATHETER RELATED BLOOD STREAM INFECTION 2H 2020 CTXR , SHOULD SEE A BREAKOUT FOR A NICE RUN
Comment:
ALSO COVID PLAY
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.